Multiple Trauma
41
2
3
23
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.8%
4 terminated out of 41 trials
85.2%
-1.3% vs benchmark
20%
8 trials in Phase 3/4
9%
2 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (41)
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
The BIG Score and In-Hospital Trauma Mortality
Evolution of Oropharyngeal and Rectal Microbiota After Severe Traumatic Brain Injury
Management of Major Trauma Patients at Aarau Trauma Center - Evaluation of Processes and Patient Outcome
Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
The Role of Serotonin in Intensive Care Patients
Proteomics in Multiple Trauma to Identify Organ Failure
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients
Intranasal Ketamine Versus Intranasal Fentanyl
INVITE Study: Invasive Instrumentation in Trauma Patients in the Shock Room
A Feasibility Study to Assess Pre Admission Status and Six Month Outcomes After Major Trauma
The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
Return to Work After Potential Severe Injury
Establishment of Regional Severe Trauma Management System
Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures
Ketamine Patient-Controlled Analgesia for Acute Pain
Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
Dynamic External Fixation in Treatment Distal Radius Fractures - Elderly Patients